Deslorelin Acetate

Verify with FDA CVM →

247 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
247
Total Reports
8
Deaths Reported
320.0%
Death Rate

Active Ingredients

Deslorelin Acetate

Administration Routes

UnknownSubcutaneousParenteralIntramuscular

Species Affected

Unknown 139
Ferret 86
Horse 12
Chicken 4
Cat 3
Dog 2
Rat 1

Most Affected Breeds

Unknown 225
Horse (unknown) 5
Quarter Horse 4
Chicken (unknown) 4
Domestic Shorthair 2
Dog (unknown) 2
Arab 1
Hanovarian 1
Mixed (Horse) 1
Cat (unknown) 1

Most Reported Reactions

Implant, Abnormal 68
Lack of efficacy - NOS 48
Difficulty of Use 45
Product defect, product difficult to use/handle (see also 'Drug device difficult to use/handle') 34
Appearance, Abnormal 24
Administration device NOS, malfunction 24
Dispenser, Abnormal 12
Administration device NOS, abnormal 12
INEFFECTIVE, OVULATION 9
Lack of hair regrowth 8
Implant, Damaged 8
Product Defect, General 6

Outcome Breakdown

Outcome Unknown
70 (68.0%)
Recovered/Normal
23 (22.3%)
Euthanized
4 (3.9%)
Died
4 (3.9%)
Ongoing
1 (1.0%)
Recovered with Sequela
1 (1.0%)

Data Summary

Metric Value
Total adverse event reports 247
Reports involving death 8
Case-fatality rate (reported events) 320.0%
Distinct species in reports 7
Distinct breeds in reports 11
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Deslorelin Acetate Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 247 adverse event reports referencing Deslorelin Acetate, including 8 reports in which the animal died — a 320.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Deslorelin Acetate. Reported administration routes include Unknown, Subcutaneous, Parenteral, Intramuscular. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Deslorelin Acetate reports are Unknown (139 reports), Ferret (86 reports), Horse (12 reports), with Unknown accounting for the largest share. Within those species, Unknown (225), Horse (unknown) (5), Quarter Horse (4) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Deslorelin Acetate are Implant, Abnormal (68), Lack of efficacy - NOS (48), Difficulty of Use (45), Product defect, product difficult to use/handle (see also 'Drug device difficult to use/handle') (34). Of the 103 reports with a coded outcome, Outcome Unknown is the leading category at 68.0%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Deslorelin Acetate.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial